Stifel maintains Buy rating on Contineum Therapeutics stock despite MS trial failure
Investing.com - Rosenblatt Securities raised its price target on Advanced Micro Devices (NASDAQ:AMD) to $300 from $225 while maintaining a Buy rating on the stock. AMD currently trades at $250.05, near its 52-week high of $267.08, with some analysts setting targets as high as $350. InvestingPro data shows AMD appears overvalued based on its Fair Value assessment.
The research firm cited AMD’s strong quarterly performance, which showed growth across all market segments. Data center revenue increased 22% year-over-year, including the ramp-up of the company’s MI350 product line. This aligns with AMD’s overall revenue growth of 27.17% in the last twelve months to $29.6 billion.
Client revenue jumped 46% compared to the same period last year, indicating continued market share gains for AMD against competitors. This growth contributed to what Rosenblatt described as a "solid beat-n-raise" quarter. With a gross profit margin of 50.99%, AMD maintains healthy profitability as it expands market share.
AMD’s outlook includes projections for double-digit percentage growth in its data center business for the upcoming quarter. This sequential growth forecast reinforces the company’s momentum in this high-margin segment. Nine analysts have recently revised their earnings expectations upward for AMD, according to InvestingPro data.
Rosenblatt believes AMD is "well positioned for well above consensus growth in 2026," which factored into its decision to significantly increase the price target by $75. The company trades at a P/E ratio of 151.2, reflecting high growth expectations. InvestingPro offers a comprehensive research report on AMD, one of 1,400+ US equities covered with deep-dive analysis and actionable insights.
In other recent news, Advanced Micro Devices (AMD) reported strong third-quarter results, with revenue from its Data Center segment growing by 22% year-over-year. This growth was attributed to strong performance in server CPUs and AI GPUs. Following these results, several analyst firms have adjusted their price targets for AMD. Wedbush raised its price target to $290, maintaining an Outperform rating, citing confidence in AMD’s growth trajectory. Morgan Stanley increased its price target to $260, with an Equalweight rating, as they anticipate the upcoming analyst day to provide insights into AMD’s MI450 opportunity. Evercore ISI also lifted its price target to $270, with an Outperform rating, after AMD’s earnings and revenue exceeded expectations. UBS set a new price target of $300, maintaining a Buy rating, and advised against selling before the upcoming analyst day. KeyBanc, however, maintained its Sector Weight rating, acknowledging the strong performance but not altering its valuation. These developments reflect a positive outlook among analysts on AMD’s future prospects.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.